Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Daphna Hutt
Locally Produced CD19 CAR T Cells Leading to Clinical Remissions in Medullary and Extramedullary Relapsed Acute Lymphoblastic Leukemia
American Journal of Hematology
Hematology
Related publications
Potent Anti-Leukemia Activities of Humanized CD19-targeted CAR-T Cells in Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia
American Journal of Hematology
Hematology
CAR T Cells for Acute Lymphoblastic Leukemia
American Journal of Hematology
Hematology
CAR-T Cells and Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia
Immunotherapy
Oncology
Allergy
Immunology
CTL019 (Tisagenlecleucel): CAR-T Therapy for Relapsed and Refractory B-Cell Acute Lymphoblastic Leukemia
Drug Design, Development and Therapy
Drug Discovery
Pharmacology
Pharmaceutical Science
CAR-T Cells: An Innovative Therapeutic Strategy Against Pediatric Acute Lymphoblastic Leukemia
Research in Molecular Medicine (RMM)
Clinical Trials of Dual-Target CAR T Cells, Donor-Derived CAR T Cells, and Universal CAR T Cells for Acute Lymphoid Leukemia
Journal of Hematology and Oncology
Cancer Research
Oncology
Hematology
Molecular Biology
Efficacy and Safety of Humanized Anti-Cd19-Car-T Therapy Following Intensive Lymphodepleting Chemotherapy for Refractory/Relapsed B Acute Lymphoblastic Leukaemia
British Journal of Haematology
Hematology
CD19 CAR-Targeted T Cells Induce Long-Term Remission and B Cell Aplasia in an Immunocompetent Mouse Model of B Cell Acute Lymphoblastic Leukemia
PLoS ONE
Multidisciplinary
Shortening the Ex Vivo Culture of CD19‐specific CAR T‐cells Retains Potent Efficacy Against Acute Lymphoblastic Leukemia Without CRES or Severe CRS
American Journal of Hematology
Hematology